3.62
price up icon0.56%   0.02
 
loading
Precedente Chiudi:
$3.60
Aprire:
$3.52
Volume 24 ore:
25,669
Relative Volume:
0.28
Capitalizzazione di mercato:
$9.69M
Reddito:
-
Utile/perdita netta:
$-22.01M
Rapporto P/E:
-0.5485
EPS:
-6.6
Flusso di cassa netto:
$-18.31M
1 W Prestazione:
+14.56%
1M Prestazione:
+30.69%
6M Prestazione:
-35.23%
1 anno Prestazione:
-71.42%
Intervallo 1D:
Value
$3.50
$3.7483
Intervallo di 1 settimana:
Value
$3.05
$3.9499
Portata 52W:
Value
$1.39
$13.02

Vaccinex Inc Stock (VCNX) Company Profile

Name
Nome
Vaccinex Inc
Name
Telefono
585-271-2700
Name
Indirizzo
1895 MOUNT HOPE AVE, ROCHESTER, NY
Name
Dipendente
40
Name
Cinguettio
@Vaccinex
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
VCNX's Discussions on Twitter

Confronta VCNX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
VCNX 3.62 9.69M 0 -22.01M -18.31M -6.60
VRTX 450.97 116.14B 10.63B -479.80M -1.35B 13.33
REGN 738.00 81.10B 13.85B 4.65B 3.32B 35.06
ARGX 605.92 36.23B 1.86B -40.29M -1.28B -4.16
ALNY 244.89 31.59B 2.09B -332.26M 16.06M -4.14
BNTX 113.13 27.12B 3.30B -501.07M 1.03B 11.54

Vaccinex Inc Stock (VCNX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2020-09-23 Downgrade BTIG Research Buy → Neutral
2018-09-04 Iniziato Ladenburg Thalmann Buy

Vaccinex Inc Borsa (VCNX) Ultime notizie

pulisher
Nov 18, 2024

Vaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Nov 18, 2024
pulisher
Nov 18, 2024

Vaccinex Reports Promising Alzheimer's Drug Data, Raises $8.35M Amid Financial Challenges | VCNX Stock News - StockTitan

Nov 18, 2024
pulisher
Nov 15, 2024

Vaccinex secures $2.15 million in private placement - Investing.com

Nov 15, 2024
pulisher
Nov 15, 2024

Vaccinex Inc (VCNX) Quarterly 10-Q Report - Quartzy

Nov 15, 2024
pulisher
Nov 15, 2024

Vaccinex secures $2.15 million in private placement By Investing.com - Investing.com UK

Nov 15, 2024
pulisher
Nov 14, 2024

ARMISTICE CAPITAL, LLC Acquires Shares in Vaccinex Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Vaccinex, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024
pulisher
Nov 08, 2024

Latest Company News - Investing.com

Nov 08, 2024
pulisher
Nov 08, 2024

Vaccinex inks multiple antibody discovery deals using ActivMAb By Investing.com - Investing.com Canada

Nov 08, 2024
pulisher
Nov 07, 2024

Vaccinex inks multiple antibody discovery deals using ActivMAb - Investing.com India

Nov 07, 2024
pulisher
Nov 07, 2024

Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC - GlobeNewswire

Nov 07, 2024
pulisher
Nov 07, 2024

Vaccinex Lands Major Pharma Deals: Amgen, Merck Partner on Breakthrough Antibody Tech | VCNX Stock News - StockTitan

Nov 07, 2024
pulisher
Nov 06, 2024

Vaccinex Reports Improved Immunity Correlating with - GlobeNewswire

Nov 06, 2024
pulisher
Nov 05, 2024

VCNXVaccinex, Inc. Latest Stock News & Market Updates - StockTitan

Nov 05, 2024
pulisher
Nov 05, 2024

Vaccinex's Pepinemab Breakthrough: New Data Shows Enhanced Cancer Immunotherapy Success | VCNX Stock News - StockTitan

Nov 05, 2024
pulisher
Nov 01, 2024

Vaccinex reports progress in Alzheimer's treatment study By Investing.com - Investing.com Canada

Nov 01, 2024
pulisher
Nov 01, 2024

Vaccinex reports progress in Alzheimer's treatment study - Investing.com India

Nov 01, 2024
pulisher
Oct 31, 2024

Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 - GlobeNewswire

Oct 31, 2024
pulisher
Oct 31, 2024

Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Madrid, Spain - Nasdaq

Oct 31, 2024
pulisher
Oct 28, 2024

Vaccinex stock tanks 40% despite positive Alzheimer’s study update - MSN

Oct 28, 2024
pulisher
Oct 25, 2024

Vaccinex Stock Spikes On 'Promising' Data On Alzheimer’s Drug Study: Retail Sentiment Brightens - Barchart

Oct 25, 2024
pulisher
Oct 24, 2024

Vaccinex to Report Promising New Efficacy Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference on October 31, 2024 - GlobeNewswire

Oct 24, 2024
pulisher
Oct 20, 2024

Micron Technology (MU-Q) QuotePress Release - The Globe and Mail

Oct 20, 2024
pulisher
Oct 15, 2024

Orange Juice (OJX25) Quote - The Globe and Mail

Oct 15, 2024
pulisher
Oct 14, 2024

Antibody Library Technology Market Report to 2032 -AnaptysBio Inc, MorphoSys AG, XOMA Corporation, Abzena Plc, AvantGen – IndiaPolitics.com - IndiaPolitics.com

Oct 14, 2024
pulisher
Oct 09, 2024

Vaccinex faces potential Nasdaq delisting over equity shortfall - Investing.com India

Oct 09, 2024
pulisher
Oct 09, 2024

BTIG Research’s latest rating for VCNX stock - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Vaccinex faces potential Nasdaq delisting over equity shortfall By Investing.com - Investing.com Canada

Oct 09, 2024
pulisher
Oct 09, 2024

Company’s Banking Shares: Up -90.42% from 52-Week Low, But Can the Momentum Hold? - The InvestChronicle

Oct 09, 2024
pulisher
Oct 09, 2024

Post-Trade Analysis: Vaccinex Inc (VCNX) Slides -27.92, Closing at 1.73 - The Dwinnex

Oct 09, 2024
pulisher
Oct 02, 2024

Vaccinex stock hits 52-week low at $2.98 amid market challenges - Investing.com

Oct 02, 2024
pulisher
Sep 25, 2024

Vaccinex stock hits 52-week low at $4.17 amid sharp annual decline - Investing.com Canada

Sep 25, 2024
pulisher
Sep 25, 2024

VSME’s price-to-free cash flow ratio: What it means for investors - US Post News

Sep 25, 2024
pulisher
Sep 25, 2024

Short Interest in Victory Square Technologies Inc. (OTCMKTS:VSQTF) Declines By 79.4% - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Viemed Healthcare, Inc. (NASDAQ:VMD) Shares Purchased by Victory Capital Management Inc. - Defense World

Sep 25, 2024
pulisher
Sep 24, 2024

WUXI BIO Buys back ~3.32M Shrs for ~$42.55M Ytd - AASTOCKS.com

Sep 24, 2024
pulisher
Sep 24, 2024

Vaxcyte Inc (PCVX) receives a Buy rating from Mizuho - Knox Daily

Sep 24, 2024
pulisher
Sep 24, 2024

Victrex plc (LON:VCT) Insider Jane Toogood Acquires 508 Shares - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Victrex Director Buys Shares, Signals Confidence - TipRanks

Sep 24, 2024
pulisher
Sep 24, 2024

Bank of New York Mellon Corp Boosts Stock Holdings in Viemed Healthcare, Inc. (NASDAQ:VMD) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

StockNews.com Initiates Coverage on Vector Group (NYSE:VGR) - Defense World

Sep 24, 2024
pulisher
Sep 23, 2024

VICR Investors Have Opportunity to Lead Vicor Corporation Securities Fraud Lawsuit with the Schall Law Firm - Business Wire

Sep 23, 2024
pulisher
Sep 23, 2024

The Gross Law Firm Reminds Vicor Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 23, 2024VICR - PR Newswire

Sep 23, 2024
pulisher
Sep 23, 2024

Victory Capital Management Inc. Has $496,000 Stock Holdings in Zymeworks Inc. (NYSE:ZYME) - Defense World

Sep 23, 2024
pulisher
Sep 23, 2024

Rhumbline Advisers Has $1.01 Million Position in V2X, Inc. (NYSE:VVX) - Defense World

Sep 23, 2024
pulisher
Sep 21, 2024

Choreo LLC Takes Position in Vector Group Ltd. (NYSE:VGR) - Defense World

Sep 21, 2024
pulisher
Sep 20, 2024

VICOR 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Vicor CorporationVICR - Business Wire

Sep 20, 2024
pulisher
Sep 20, 2024

VICR FINAL DEADLINE: ROSEN, A GLOBAL AND LEADING LAW FIRM, - GlobeNewswire

Sep 20, 2024
pulisher
Sep 20, 2024

First Eagle Investment Management LLC Purchases 2,067 Shares of V2X, Inc. (NYSE:VVX) - Defense World

Sep 20, 2024
pulisher
Sep 20, 2024

Vaccinex issues new warrants, secures $6.2 million in funding - Investing.com

Sep 20, 2024
pulisher
Sep 20, 2024

Victory Capital Management Inc. Cuts Stake in Wyndham Hotels & Resorts, Inc. (NYSE:WH) - Defense World

Sep 20, 2024

Vaccinex Inc Azioni (VCNX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$71.72
price up icon 1.89%
$19.00
price up icon 3.15%
$41.11
price up icon 7.48%
$372.89
price up icon 1.51%
$190.51
price down icon 2.08%
$113.13
price up icon 4.53%
Capitalizzazione:     |  Volume (24 ore):